Coronavirus disease 2019 (COVID‐19) is spreading worldwide, and has been declared as an international public health concern. Patients with lung cancer are highly susceptible to infection compared to healthy individuals because of systemic immunosuppression induced by malignancy and anticancer therapy. Furthermore, patients with cancer demonstrate poorer outcomes following infection. Hence, patients with lung cancer should be considered a priority group for COVID‐19 prevention. Furthermore, the routine treatment of patients with cancer has been affected during the COVID‐19 pandemic, and patients may not have been able to undergo timely and effective antitumor treatment, thereby indicating a poor prognosis. Here, we provide some suggestions for early identification of COVID‐19 and differential diagnosis in patients with lung cancer who have fever and respiratory symptoms. Our medical team also provide clinical recommendations on lung cancer management during the COVID‐19 pandemic, for carrying out meticulous and individualized clinical management of lung cancer patients and maximum protection to effectively prevent COVID‐19.

中文翻译：

---

COVID-19 大流行期间肺癌管理的临床建议。


2019 年冠状病毒病 (COVID-19) 正在全球范围内传播，并已被宣布为国际公共卫生问题。由于恶性肿瘤和抗癌治疗引起的全身免疫抑制，与健康个体相比，肺癌患者非常容易受到感染。此外，癌症患者在感染后表现出较差的结果。因此，肺癌患者应被视为预防 COVID-19 的优先人群。此外，癌症患者的常规治疗在COVID-19大流行期间受到影响，患者可能无法接受及时有效的抗肿瘤治疗，从而表明预后不良。在此，我们为有发热和呼吸道症状的肺癌患者早期识别 COVID-19 和鉴别诊断提供一些建议。我们的医疗团队还提供了COVID-19大流行期间肺癌管理的临床建议，对肺癌患者进行细致、个体化的临床管理，最大限度地提供保护，有效预防COVID-19。